AMAG PHARMACEUTICALS INC has a total of 22 patent applications. It decreased the IP activity by 100.0%. Its first patent ever was published in 2000. It filed its patents most often in United States, EPO (European Patent Office) and WIPO (World Intellectual Property Organization). Its main competitors in its focus markets pharmaceuticals, micro-structure and nano-technology and measurement are GILROSE PHARMACEUTICALS LLC, FEDERALNOE GOSUDARSTVENNOE BYUDZHETNOE OBRAZOVATELNOE UCHREZHDENIE VYSSHEGO OBRAZOVANIYA KIROVSKIJ G and WANG HONGKUI.
# | Country | Total Patents | |
---|---|---|---|
#1 | United States | 12 | |
#2 | EPO (European Patent Office) | 3 | |
#3 | WIPO (World Intellectual Property Organization) | 3 | |
#4 | Canada | 2 | |
#5 | Japan | 1 | |
#6 | Luxembourg | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Micro-structure and nano-technology | |
#3 | Measurement | |
#4 | Medical technology | |
#5 | Organic fine chemistry |
# | Technology | |
---|---|---|
#1 | Medical preparations | |
#2 | Nanostructure applications | |
#3 | Therapeutic chemical compounds | |
#4 | Measuring electric variables | |
#5 | Diagnosis and surgery | |
#6 | Organic chemistry methods | |
#7 | Steroids |
# | Name | Total Patents |
---|---|---|
#1 | Lewis Jerome M | 8 |
#2 | Jozwiakowski Michael J | 7 |
#3 | Birch Robert | 7 |
#4 | Bengele Howard | 7 |
#5 | Paul Kenneth G | 7 |
#6 | Groman Ernest V | 7 |
#7 | Frigo Timothy B | 7 |
#8 | Wolf Gerald L | 5 |
#9 | Winchester Gary | 4 |
#10 | Haraldsen Kyle | 4 |
Publication | Filing date | Title |
---|---|---|
EP3458070A1 | Polymeric extended release compositions of hydroxyprogesterone caproate and methods of using same | |
US9844558B1 | Methods of reducing risk of preterm birth | |
WO2017059070A1 | Crystalline and amorphous form of 17-a- hydroxyprogesterone caproate | |
US2015297757A1 | Macrophage-enhanced mri (memri) in a single imaging session | |
CA2691664A1 | Macrophage-enhanced mri (memri) | |
US7871597B2 | Polyol and polyether iron oxide complexes as pharmacological and/or MRI contrast agents | |
EP1169062A2 | Heat stable coated colloidal iron oxides |